A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas (Q90072409)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 September 2019
edit
Language Label Description Also known as
English
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
scientific article published on 12 September 2019

    Statements

    title
    A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    31512497
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31512497%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    11 April 2020
    author name string
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q90072409&oldid=1528574517"